Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inhibition of DMBA-induced mammary tumorigenesis by rosemary extract

Conference · · FASEB Journal (Federation of American Societies for Experimental Biology); (United States)
OSTI ID:5214995
 [1]
  1. Univ. of Illinois, Urbana (United States)
Extracts of the spice, rosemary, have exhibited potent antioxidant properties. In order to evaluate the ability of rosemary extract to inhibit mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA), two groups of 32 day old female SD rats weighing 99.4 {plus minus} 2.6 g were fed semipurified diets containing either 0 or 1.0% rosemary extract during both the initiation and promotion stages of tumor development. All rats were administered DMBA at 53 days of age. Terminal tumor incidence was 75% and 40% for rats fed the 0 and 1.0% diets, respectively. Tumors/tumor-bearing rat were 2.3 {plus minus} 0.5 and 1.8 {plus minus} 0.3, respectively. In a second study 3 groups of female rats were fed diets containing 0, 0.5 or 1.0% rosemary extract for {minus}3 to +2 weeks following DMBA administration at 53 days of age. By 13 weeks post-DMBA tumor incidence for rats fed the 1.0% rosemary diet was significantly less than for rats fed the control diet. However, by 20, weeks, incidence for rats fed 0, 0.5, and 1.0% rosemary was 72.2, 69.6 and 58.3%, respectively. Tumors/tumor bearing rat were 2.2 {plus minus} 0.3, 2.0 {plus minus} 0.4 and 2.4 {plus minus} 0.5 for rats fed the 0, 0.5 and 1.0% diets, respectively. Therefore, rosemary extract can inhibit DMBA-induced mammary tumorigenesis when fed prior to and after DMBA dosing. Its antitumorigenic effect is not due to inhibition of the initiation stage alone.
OSTI ID:
5214995
Report Number(s):
CONF-9104107--
Conference Information:
Journal Name: FASEB Journal (Federation of American Societies for Experimental Biology); (United States) Journal Volume: 5:5
Country of Publication:
United States
Language:
English

Similar Records

Influence of dietary menhaden oil on 7,12-dimethylbenzanthracene induced mammary tumorigenesis in rats
Conference · Tue Mar 04 23:00:00 EST 1986 · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) · OSTI ID:6962295

Inhibition of mammary tumor promotion by dietary D,L-2-difluoromethylornithine in combination with omega-3 and omega-6 fatty acids
Conference · Sun Feb 25 23:00:00 EST 1990 · FASEB Journal (Federation of American Societies for Experimental Biology); (United States) · OSTI ID:6058197

Decreased adrenal medullary tyrosine hydroxylase mRNA in DMBA (7,12-dimethylbenz(a)anthracene)-induced mammary carcinoma
Conference · Thu Mar 14 23:00:00 EST 1991 · FASEB Journal (Federation of American Societies for Experimental Biology); (United States) · OSTI ID:5146458